Maintaining Compliance of Clinical Sites with Regards to the FDA Draft Guidance on (Risk-Based Approach to Monitoring) - Webinar By GlobalCompliancePanel

18 July 2012, Wilmington, United States

Introduction

Monitoring of clinical sites is a critical part of the Good Clinical Practices. With the advent of electronic data capture (EDC processes and more recently the FDA guidance, Oversight of Clinical Investigations-a Risk-based Approach to Monitoring some changes in the way we monitor sites and the data collection are taking place.